Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.

Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP.

Pediatr Blood Cancer. 2011 Sep;57(3):506-13. doi: 10.1002/pbc.22899.

2.

Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.

Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.

Pediatr Blood Cancer. 2007 Mar;48(3):278-84.

PMID:
16456857
3.

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.

Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS.

Bone Marrow Transplant. 1998 Oct;22(7):661-7.

4.

High-dose thiotepa and etoposide in children with poor-prognosis brain tumors.

Fagioli F, Biasin E, Mastrodicasa L, Sandri A, Ferrero I, Berger M, Vassallo E, Madon E.

Cancer. 2004 May 15;100(10):2215-21.

6.
7.

High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

Pérez-Martínez A, Lassaletta A, González-Vicent M, Sevilla J, Díaz MA, Madero L.

J Neurooncol. 2005 Jan;71(1):33-8.

PMID:
15719272
8.

Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.

Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL.

J Clin Oncol. 2004 May 15;22(10):1934-43.

PMID:
15143087
10.
11.

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.

Dunkel IJ, Garvin JH Jr, Goldman S, Ettinger LJ, Kaplan AM, Cairo M, Li H, Boyett JM, Finlay JL.

J Neurooncol. 1998 Mar;37(1):67-73.

PMID:
9525840
12.

A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors.

Foreman NK, Schissel D, Le T, Strain J, Fleitz J, Quinones R, Giller R.

J Neurooncol. 2005 Jan;71(2):181-7.

PMID:
15690136
13.
14.

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.

Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein FG, Schulz A, Wawer A, Zintl F, Graf N.

Bone Marrow Transplant. 2002 Dec;30(12):893-8.

15.

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.

Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Celebi H, Ustün C, Akan H, Demirer S, Aydintuğ S, Uysal A, Koç H.

Bone Marrow Transplant. 2000 Apr;25(7):697-703.

16.

High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.

Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H.

Bone Marrow Transplant. 2003 May;31(9):755-61.

PMID:
12732881
17.

A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.

Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS.

J Neurooncol. 1999 Sep;44(2):155-62.

PMID:
10619499
18.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.

Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E 3rd, Ayash L.

Bone Marrow Transplant. 2001 Feb;27(3):269-78.

19.
20.

Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.

Gilheeney SW, Khakoo Y, Souweidane M, Wolden S, Boulad F, Dunkel IJ.

Pediatr Blood Cancer. 2010 Apr;54(4):591-5. doi: 10.1002/pbc.22347.

PMID:
19998470

Supplemental Content

Support Center